Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd. is a prominent pharmaceutical company involved in research, development, manufacturing, and marketing of a wide range of pharmaceutical products. Its primary aim is to advance the field of medicine by focusing on the development of innovative therapies that address unmet medical needs. Chugai operates primarily in the fields of oncology, renal disease, and bone and joint diseases, leveraging its capabilities in biotechnology antibody pharmaceuticals. Notably, the company collaborates closely with Roche Group, enabling it to leverage advanced science and technology in drug discovery and development. Chugai's influence is significant in both Japanese and global markets, as it continues to contribute to the enhancement of healthcare by providing high-quality pharmaceutical solutions. Founded in 1925, Chugai is strongly committed to its mission of providing valuable products and services that align with the needs of patients and healthcare providers worldwide.

CEO

Dr. Osamu Okuda

Employees

5,026

Website

chugai-pharm.co.jp